FDA Investigator Inga M Warr
Inga M Warr has conducted inspections on 24 sites in 1 countries as of 24 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
24 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Inga M Warr:
Adaliz Santaliz Cruz,
Adam R Cooke,
Althea A Williams,
Ana L Kewes,
Ann B Borromeo,
Babatunde D Babalola,
Barbara M Frazier,
Barbara T Carmichael,
Brandy D Brown,
Brentley S Collins,
Brian R Hendricks,
Brittny C Cargo,
Calvin Foulks,
Camerson E Moore,
CDR Thomas R Berry, PPh,
Charanjeet Jassal,
Christopher B May,
Christopher S Keating,
Claudette D Brooks,
Cordelia J Brammer,
David E Lowe,
Dawn M Braswell,
Dellarese L Herbert,
Derek C Price,
Dr. Sriram Subramaniam, PhD,
Edward E Lockwood (EEL),
Ernest H Blackwood,
Fulton A Varner,
Gamal A Norton,
George T Allen, Jr,
Gretchen M Laws,
Helen R Bester,
Ibad U Khan,
Jared P Stevens,
Jason F Chancey,
Jawaid Hamid,
Jessica A Stephens,
Kara D Dobbin,
Karen A Coleman,
Kathleen D Culver,
Kimberly Cdelk Brooks,
Kip J Hanks,
Latonya T Jiggetts,
Leslie W Gilbert,
Libia M Lugo,
Marian A Kainer,
Maricelys Mercado,
Mary A Millner,
Mary L Schuckmann,
Matthew A Humbard,
Melanie M Walker,
Melanie W Pishnery,
Miaja Umaedi,
Michael P Sweeney,
Michelle D Haamid,
Myoshi M Francis,
Nicholas Z Lu,
Patricia F Hudson,
Paul A Bonneau,
Paul W Moy,
Perry H Gambrell,
Philip F Istafanos, DMV, MS,
Randy L Clarida,
Rhonda Alexander,
Richard L Bartlett,
Ronnie E Jackson,
Rose Xu,
Samantha E Cleek,
Samuel L Murray,
Sarah Forney,
Sayeeda Hdabe,
Seneca D Toms,
Sonya M Edmonds,
Srinivas R Chennamaneni, PhD,
Stephanie E Hubbard,
Tajah L Blackburn,
Tammara A Stephens,
Trang N Cox,
Travis S Bradley,
Vanessa E Coulter,
Veronica Fuentes, MS,
Vincent M Williams,
Viviana Matta,
William S Boivin,
Xiomara Copeland
Inga M Warr's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more